vs
费森尤斯医疗（FMS）与康宁（GLW）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是康宁的1.3倍（$5.5B vs $4.2B），康宁净利率更高（12.8% vs 7.9%，领先4.9%），康宁同比增速更快（20.4% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
康宁是1851年成立的美国跨国科技企业，主营玻璃、陶瓷及相关材料技术，产品线涵盖先进光学产品，主要应用于工业与科研领域。20世纪曾推出多款知名消费产品，包括康宁锅、Corelle餐具、Pyrex烘焙玻璃器皿等，广受市场欢迎。
FMS vs GLW — 直观对比
营收规模更大
FMS
是对方的1.3倍
$4.2B
营收增速更快
GLW
高出20.7%
-0.3%
净利率更高
GLW
高出4.9%
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $4.2B |
| 净利润 | $434.2M | $540.0M |
| 毛利率 | 27.4% | 35.5% |
| 营业利润率 | 11.7% | 15.9% |
| 净利率 | 7.9% | 12.8% |
| 营收同比 | -0.3% | 20.4% |
| 净利润同比 | 240.4% | 74.2% |
| 每股收益（稀释后） | — | $0.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSGLW
| Q4 25 | $5.5B | $4.2B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $3.5B | ||
| Q4 24 | $5.5B | $3.5B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | — | $3.3B | ||
| Q1 24 | — | $3.0B |
净利润FMSGLW
| Q4 25 | $434.2M | $540.0M | ||
| Q3 25 | — | $430.0M | ||
| Q2 25 | — | $469.0M | ||
| Q1 25 | — | $157.0M | ||
| Q4 24 | $127.6M | $310.0M | ||
| Q3 24 | — | $-117.0M | ||
| Q2 24 | — | $104.0M | ||
| Q1 24 | — | $209.0M |
毛利率FMSGLW
| Q4 25 | 27.4% | 35.5% | ||
| Q3 25 | — | 37.1% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 35.2% | ||
| Q4 24 | 25.0% | 34.2% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 33.4% |
营业利润率FMSGLW
| Q4 25 | 11.7% | 15.9% | ||
| Q3 25 | — | 14.4% | ||
| Q2 25 | — | 14.8% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | 5.1% | 11.2% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 8.5% |
净利率FMSGLW
| Q4 25 | 7.9% | 12.8% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 2.3% | 8.9% | ||
| Q3 24 | — | -3.5% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 7.0% |
每股收益（稀释后）FMSGLW
| Q4 25 | — | $0.61 | ||
| Q3 25 | — | $0.50 | ||
| Q2 25 | — | $0.54 | ||
| Q1 25 | — | $0.18 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | — | $-0.14 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $1.5B |
| 总债务越低越好 | — | $7.6B |
| 股东权益账面价值 | $15.4B | $11.8B |
| 总资产 | $33.5B | $31.0B |
| 负债/权益比越低杠杆越低 | — | 0.65× |
8季度趋势，按日历期对齐
现金及短期投资FMSGLW
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | $1.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务FMSGLW
| Q4 25 | — | $7.6B | ||
| Q3 25 | — | $7.4B | ||
| Q2 25 | — | $6.7B | ||
| Q1 25 | — | $7.0B | ||
| Q4 24 | — | $6.9B | ||
| Q3 24 | — | $7.1B | ||
| Q2 24 | — | $6.9B | ||
| Q1 24 | — | $7.0B |
股东权益FMSGLW
| Q4 25 | $15.4B | $11.8B | ||
| Q3 25 | — | $11.5B | ||
| Q2 25 | — | $11.1B | ||
| Q1 25 | — | $10.7B | ||
| Q4 24 | $17.0B | $10.7B | ||
| Q3 24 | — | $11.1B | ||
| Q2 24 | — | $10.6B | ||
| Q1 24 | — | $11.2B |
总资产FMSGLW
| Q4 25 | $33.5B | $31.0B | ||
| Q3 25 | — | $29.9B | ||
| Q2 25 | — | $28.7B | ||
| Q1 25 | — | $27.4B | ||
| Q4 24 | $36.3B | $27.7B | ||
| Q3 24 | — | $28.3B | ||
| Q2 24 | — | $27.2B | ||
| Q1 24 | — | $27.6B |
负债/权益比FMSGLW
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 0.64× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 0.65× | ||
| Q4 24 | — | 0.64× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $1.1B |
| 自由现金流经营现金流 - 资本支出 | — | $620.0M |
| 自由现金流率自由现金流/营收 | — | 14.7% |
| 资本支出强度资本支出/营收 | — | 10.2% |
| 现金转化率经营现金流/净利润 | 6.67× | 1.95× |
| 过去12个月自由现金流最近4个季度 | — | $1.4B |
8季度趋势，按日历期对齐
经营现金流FMSGLW
| Q4 25 | $2.9B | $1.1B | ||
| Q3 25 | — | $784.0M | ||
| Q2 25 | — | $708.0M | ||
| Q1 25 | — | $151.0M | ||
| Q4 24 | $2.6B | $623.0M | ||
| Q3 24 | — | $699.0M | ||
| Q2 24 | — | $521.0M | ||
| Q1 24 | — | $96.0M |
自由现金流FMSGLW
| Q4 25 | — | $620.0M | ||
| Q3 25 | — | $450.0M | ||
| Q2 25 | — | $400.0M | ||
| Q1 25 | — | $-57.0M | ||
| Q4 24 | — | $369.0M | ||
| Q3 24 | — | $482.0M | ||
| Q2 24 | — | $279.0M | ||
| Q1 24 | — | $-156.0M |
自由现金流率FMSGLW
| Q4 25 | — | 14.7% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 10.4% | ||
| Q1 25 | — | -1.7% | ||
| Q4 24 | — | 10.5% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | -5.2% |
资本支出强度FMSGLW
| Q4 25 | — | 10.2% | ||
| Q3 25 | — | 8.1% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 6.4% | ||
| Q2 24 | — | 7.4% | ||
| Q1 24 | — | 8.5% |
现金转化率FMSGLW
| Q4 25 | 6.67× | 1.95× | ||
| Q3 25 | — | 1.82× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 0.96× | ||
| Q4 24 | 20.20× | 2.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.01× | ||
| Q1 24 | — | 0.46× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
